Clinical Trials · NCT03511196
Intermittent Androgen Deprivation Therapy for Stage IV Castration Sensitive Prostate Cancer
- Phase
- EARLY_Phase 1
- Recruitment status
- Active Not Recruiting
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute
- Enrollment
- 17
- Start date
- Sep 2018
- Locations
- 1 site, United States
- Primary endpoint
- Rate of Participant Retention